“We are launching a retooling process, the reconstruction of Calan plant and its retooling is underway. We hope the entire investment will be completed in 2023. The EU fund-based project amounts to EUR2.5 million,” said Daniel Cosman, Coramed shareholder.
Coramed’s clients are hospitals, clinics, but also individuals and the company works with pharmacies and also sells online, on its own website.
Coramed increased tenfold the mask production capacity amid the pandemic, being able to produce as many as 50,000 items per day.
The company saw significant growth in 2020 on the year, from RON7.2 million to RON16.6 million. About 2021, the entrepreneur says turnover dropped by 20%, meaning it reached over RON13 million, in line with ZF calculations.
(English version by Catalina Apostoiu)